Altogether, although further studies are warranted in order to fully clarify the role of FABP4 in the cellular responses underlying these processes, increasing evidence highlights an active role of both exogenous and liver-expressed FABP4 in the onset and progression of the MAFLD and hepatocellular carcinoma (Figure 1). Here, FABP4 is linked to hepatocellular carcinoma.